Vision
To be the world’s top pharmaceutical company in the field of metabolic disease.

Our Mission
“To discover novel therapeutics for metabolic diseases with unmet medical needs to help people live longer and healthier”

Our Goal

Since 2020
Expanding the drug pipeline and making global licensing deals

Surveying unmet medical needs
Searching for novel biomarkers that meet unmet medical needs
Initiating first-in-class drug development using novel biomarkers
Making technology licensing deals

Since 2019
Initiating collaborative research with bio ventures

Providing medicinal chemistry services to partners
Accumulating knowledge and experience for novel drug development
Creating a stable sales revenue

Since 2017
Developing drug candidates for metabolic diseases

NAFLD/NASH
Inflammatory bowel disease
Other diseases

A Therapeutic Compound for Obesity and NASH - Video